Comac Medical has successfully completed Phase 1 of Horizon 2020 SME Instrument and has submitted the project report which has been approved by the European Commission.
Horizon 2020 SME Instrument Phase 1 successfully completed
August 27, 2015
Share:
News
Planning a clinical trial comes with numerous challenges, requiring a methodical approach for successful execution. However, unforeseen issues...
Abstract: In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the serum of 120...
Landmark Changes Position Company for Continued Growth and Innovation Sofia, December 6, 2023 – Comac Medical, a leading...